跳转至内容
Merck
CN

MSNU030

MultiScreen-PCR96 过滤板

Purification of PCR products

别名:

Montage PCR Kit

登录 查看组织和合同定价。

选择尺寸


关于此项目

UNSPSC Code:
41104923
NACRES:
NB.15
eCl@ss:
32039006
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

产品名称

MultiScreen-PCR96 过滤板, Purification of PCR products

material

flat bottom wells
polystyrene

sterility

non-sterile

feature

lid

manufacturer/tradename

MultiScreen®

parameter

100 μL sample volume (per well)

technique(s)

DNA purification: suitable
PCR: suitable
activity assay: suitable (with precipitations)
ligand binding assay: suitable
receptor binding assay: suitable

plate size

96 wells

well maximum volume

300 μL

working volume

150-300 μL

pore size

pore sizeproprietary

application(s)

sample preparation

binding type

low binding surface

shipped in

ambient

Quality Level

Application

MultiScreen-PCR96过滤板适用于:

  • 受体/配体结合测定
  • 样本制备
  • 采用沉淀法进行酶分析
  • DNA纯化
  • 聚合酶链反应(PCR)
  • 纯化聚合酶链反应(PCR)产物进行突变分析
  • 纯化PCR产物以检测CAG重复序列
  • 纯化PCR产物进行测序

Features and Benefits

专有膜

General description

聚合酶链式反应(PCR)是分子生物学中一项非常高效的基础技术。它提供了一种快速、有效的方法,从不同来源的核酸中利用酶的过程在实验室环境中扩增特定DNA或RNA序列。我们拥有广泛的PCR耗材和设备,旨在促进您每个阶段的PCR工作流程。MultiScreen-PCR96过滤板可用于纯化PCR产物,用于后续下游应用。

Other Notes

不包括试剂
自动化兼容:是
研究类别
测定
核酸
蛋白质

Physical form

色码:透明

Legal Information

MULTISCREEN is a registered trademark of Merck KGaA, Darmstadt, Germany

存储类别

10-13 - German Storage Class 10 to 13


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Loss, mutation and deregulation of L3MBTL4 in breast cancers
Klouche LA, et al.
Molecular Cancer (2010)
Young-Joo Kim et al.
International journal of cancer, 143(12), 3155-3168 (2018-07-11)
Somatic mutations in the telomerase reverse transcriptase (TERT) promoter are related to telomerase activation and frequently occur at two hot spots located at -124 and -146 bp relative to the start codon in various cancers. Here, we investigated the occurrence
Wooseok Im et al.
Scientific reports, 5, 16887-16887 (2015-11-21)
Mutant huntingtin (mHtt) aggregation in the nucleus is the most readily apparent phenotype and cause of neuronal death in Huntington's disease (HD). Inhibiting mHtt aggregation reduces cell death in the brain and is thus a promising therapeutic approach. The results

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持